Barry Gause
Directeur Technique/Scientifique/R&D chez SAIC-Frederick, Inc.
Postes actifs de Barry Gause
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
SAIC-Frederick, Inc.
 SAIC-Frederick, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Leidos Holdings, Inc., SAIC-Frederick, Inc. provides technical solutions and services. The company is based in San Diego, CA. David Heimbrook has been the CEO of the company since 2011. | Directeur Technique/Scientifique/R&D | 01/11/2006 | - |
Historique de carrière de Barry Gause
Anciens postes connus de Barry Gause
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Howard University | Corporate Officer/Principal | - | - |
Neogenix Oncology, Inc.
 Neogenix Oncology, Inc. Medical SpecialtiesHealth Technology Founded in December 2003, Neogenix Oncology is a clinical stage biotechnology company focused on developing therapeutic and diagnostic products for the early detection and treatment of cancer. The company's antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. Neogenix Oncology is uniquely positioned to create innovative therapeutics through the use of proprietary cancer vaccines, several of which have demonstrated success in human trials. By marrying this platform with today's breakthrough technologies, the company is developing antibody therapeutics that could change the way it detects and treats cancer. | Directeur/Membre du Conseil | 14/04/2010 | - |
| Independent Dir/Board Member | 29/02/2012 | 16/07/2012 |
Formation de Barry Gause
| Michigan State University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Neogenix Oncology, Inc.
Neogenix Oncology, Inc. Medical SpecialtiesHealth Technology Founded in December 2003, Neogenix Oncology is a clinical stage biotechnology company focused on developing therapeutic and diagnostic products for the early detection and treatment of cancer. The company's antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. Neogenix Oncology is uniquely positioned to create innovative therapeutics through the use of proprietary cancer vaccines, several of which have demonstrated success in human trials. By marrying this platform with today's breakthrough technologies, the company is developing antibody therapeutics that could change the way it detects and treats cancer. | Health Technology |
SAIC-Frederick, Inc.
SAIC-Frederick, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Leidos Holdings, Inc., SAIC-Frederick, Inc. provides technical solutions and services. The company is based in San Diego, CA. David Heimbrook has been the CEO of the company since 2011. | Commercial Services |
- Bourse
- Insiders
- Barry Gause
- Expérience
